Enhancing Pediatric and Adolescent Diabetes Care Through the Use of Continuous Glucose Monitoring and Ambulatory Glucose Profiles
Course Description:In this course, you’ll compare the differences and similarities in pediatric glycemic outcomes across regions of the world; discuss key elements of initiatives to improve outcomes and quality of diabetes care; and assess the value of ambulatory glucose profiles and continuous glucose monitoring to improve glycemic outcomes. Originally presented at the 45th Annual International Society for Pediatric and Adolescent Diabetes Conference.
- CDR Level: 2
- Suggested Learning Codes: 6.1.2, 6.2.3, 8.3.1, 8.3.5
- Run Time: 45
Course Instructor Bio(s)
David Maahs, MD, PhD
Dr David M. Maahs is Professor of Pediatrics and Division Chief of Pediatric Endocrinology at Stanford University and the Lucile Packard Children’s Hospital. He earned his MD followed by Pediatric Residency at the University of New Mexico. After 3 years on New Mexico’s faculty, Dr. Maahs completed a Pediatric Endocrinology fellowship and a concurrent PhD in Epidemiology at the University of Colorado. He remained on Colorado’s faculty for 10 years, advancing to Professor of Pediatrics before moving to Stanford. Prior to his medical career, Dr. Maahs received a BA and MA in English from the University of Kansas and was inspired to pursue a medical career after serving in the Peace Corps with assignments in Tunisia and the Central African Republic.
Dr. Maahs’ leadership experiences include being a past co-Chair (2013-16) for Protocols and Publications with the Type 1 Diabetes Exchange for which he continues as a Steering Committee member and Director of International Collaborations. This complements his role as Secretary-General for the International Society of Pediatric and Adolescent Diabetes (ISPAD, 2016-20) and Editor-in-Chief for the 2018 ISPAD Clinical Practice Consensus Guidelines. He currently serves on the Professional Practice Committee for the American Diabetes Association (ADA, 2016-18), which writes the annual ADA Standards of Care. Previously, he served on the ADA Scientific Sessions committee representing the Council on Youth. He has also served on national committees for the American Heart Association, the Pediatric Endocrine Society, and multiple journal editorial boards and review committees.
His scholarly interest is improving care and preventing complications in people with type 1 diabetes (T1D). Along with Dr Peter Chase, he is author of the 12th and 13th editions of Understanding Diabetes, or ‘Pink Panther,’ which are the most widely used educational books for children newly diagnosed with T1D, distributed internationally by the Juvenile Diabetes Research Fund (JDRF). More specifically, he has conducted epidemiologic studies that help generate hypotheses for clinical studies, including trials to develop artificial pancreas systems to improve glucose control, lower disease burden, and prevent diabetic complications. He is author or co-author of over 300 research publications. His multi-disciplinary research has been funded by the JDRF, the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), the Helmsley Charitable Trust, and the National Science Foundation (NSF).
Dr Maahs is Associate Director for the recently formed and NIDDK P30 funded Stanford University Diabetes Research Center (https://sdrc.stanford.edu). His collaborations extend to his role as Principal Investigator (PI) or steering committee member for NIH funded multi-center clinical trials including the FLEX, PERL, and ACTION studies as well as multiple Artificial Pancreas clinical trials. Education, mentorship, and training leadership includes being Program Director with Dr. Georgeanna Klingensmith on the Barbara Davis Center T32 and K12 training grants in Pediatric Endocrinology while at the University of Colorado. He is the PI on the Stanford NIH funded K12 "Training Research Leaders in Type 1 Diabetes.'
Fiona Campbell, MD, MBCHB, MRCP, FRCPCH, DCH
Dr Campbell has been a Consultant in Paediatric Diabetes for 23 years. She was the Yorkshire and Humber Strategic Clinical Network Lead for Children from 2013-2015. She was then appointed to her current part time management role of Associate Medical Director at Leeds Teaching Hospitals NHS Trust responsible for Children and Young People’s Services and Trust-wide Clinical Lead for Transition.
Clinically she leads a large diabetes service at Leeds Children’s Hospital, Leeds. England, UK caring for over 480 patients aged 0-20 years. The Leeds diabetes team has a national and international reputation for research and innovative practice especially in the use of diabetes related technologies and integrating their use into routine clinical care.
Dr Campbell has always had a particular interest in improving care quality and has been involved in many quality improvement initiatives in Children and Young Peoples diabetes care over the last 20 years. She has had a special interest in the use of data to improve outcomes and decrease the variation seen in standards of care both locally in her own service but also regionally, nationally and internationally and encouraged others to share good practice to improve care.
attended a live program?
FREQUENTLY ASKED QUESTIONS
continuing medical education courses